Sirgel, F. A., Warren, R. M., Böttger, E. C., Klopper, M., Victor, T. C., & van Helden, P. D. (2013). The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks. Public Library of Science.
Chicago Style CitationSirgel, Frederick A., Robin M. Warren, Erik C. Böttger, Marisa Klopper, Thomas C. Victor, i Paul D. van Helden. The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks. Public Library of Science, 2013.
Cita MLASirgel, Frederick A., et al. The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks. Public Library of Science, 2013.
Atenció: Aquestes cites poden no estar 100% correctes.